Nifty
Sensex
:
:
11930.35
40685.50
33.90 (0.28%)
127.01 (0.31%)

Medical Equipment/Supplies/Accessories

Rating :
76/99  (View)

BSE: 531768 | NSE: POLYMED

493.30
8.70 (1.80%)
23-Oct-2020 | 3:54PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  487.05
  •  499.55
  •  484.50
  •  484.60
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  100236
  •  494.46
  •  542.75
  •  190.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 4,283.51
  • 41.68
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 4,460.45
  • 0.41%
  • 9.30

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 48.76%
  • 0.00%
  • 18.14%
  • FII
  • DII
  • Others
  • 2.86%
  • 0.01%
  • 30.23%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.79
  • 10.76
  • 9.71

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.01
  • 13.61
  • 6.38

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 16.01
  • 14.58
  • 10.57

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 28.76
  • 29.15
  • 27.93

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.37
  • 6.94
  • 6.50

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.27
  • 17.32
  • 16.38

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 20
Jun 19
Var%
Mar 20
Mar 19
Var%
Dec 19
Dec 18
Var%
Sep 19
Sep 18
Var%
Net Sales
170
162
5%
171
172
-1%
180
155
17%
174
150
16%
Expenses
125
125
-1%
131
138
-5%
135
124
8%
132
116
14%
EBITDA
46
36
26%
40
34
19%
46
30
50%
42
34
22%
EBIDTM
27%
23%
14%
20%
25%
20%
24%
23%
Other Income
3
4
-17%
5
7
-26%
4
4
7%
5
4
22%
Interest
3
3
-14%
8
2
292%
5
-1
-
2
7
-76%
Depreciation
11
10
10%
9
10
-1%
11
10
11%
10
9
11%
PBT
36
27
30%
28
29
-5%
33
25
33%
35
23
54%
Tax
10
8
20%
6
8
-22%
9
9
-9%
7
9
-18%
PAT
26
19
34%
22
21
2%
25
16
58%
28
14
98%
PATM
15%
12%
7%
12%
14%
10%
16%
9%
EPS
2.95
2.20
34%
2.45
2.41
2%
2.81
1.77
59%
3.17
1.60
98%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Net Sales
696
687
611
520
455
412
390
322
260
217
173
Net Sales Growth
9%
13%
17%
14%
10%
6%
21%
24%
20%
25%
 
Cost Of Goods Sold
4,814
170
165
125
117
114
111
83
66
59
52
Gross Profit
-4,118
517
446
396
338
298
280
239
194
158
121
GP Margin
-592%
75%
73%
76%
74%
72%
72%
74%
75%
73%
70%
Total Expenditure
523
521
480
398
362
324
304
247
207
169
135
Power & Fuel Cost
-
26
25
19
17
15
13
11
10
8
7
% Of Sales
-
4%
4%
4%
4%
4%
3%
3%
4%
4%
4%
Employee Cost
-
139
117
99
87
75
65
53
42
34
27
% Of Sales
-
20%
19%
19%
19%
18%
17%
16%
16%
16%
16%
Manufacturing Exp.
-
131
122
113
97
85
84
68
55
40
32
% Of Sales
-
19%
20%
22%
21%
21%
21%
21%
21%
18%
19%
General & Admin Exp.
-
33
30
21
21
17
14
16
9
8
7
% Of Sales
-
5%
5%
4%
5%
4%
4%
5%
3%
4%
4%
Selling & Distn. Exp.
-
15
16
14
17
13
14
10
8
9
7
% Of Sales
-
2%
3%
3%
4%
3%
4%
3%
3%
4%
4%
Miscellaneous Exp.
-
8
6
7
6
5
4
6
17
11
7
% Of Sales
-
1%
1%
1%
1%
1%
1%
2%
6%
5%
2%
EBITDA
173
166
131
122
93
88
86
76
53
48
38
EBITDA Margin
25%
24%
21%
23%
21%
21%
22%
23%
20%
22%
22%
Other Income
18
18
18
14
14
8
8
1
0
1
0
Interest
18
20
14
12
9
10
10
9
7
8
5
Depreciation
42
41
37
29
24
21
19
14
13
12
9
PBT
132
124
99
96
75
65
65
53
33
29
23
Tax
31
30
35
26
20
18
23
19
10
10
2
Tax Rate
24%
24%
35%
27%
27%
27%
27%
30%
30%
33%
10%
PAT
100
94
64
69
55
47
62
44
23
19
21
PAT before Minority Interest
100
94
64
69
55
47
62
44
23
19
21
Minority Interest
0
0
0
0
0
0
0
0
0
0
0
PAT Margin
14%
14%
10%
13%
12%
12%
16%
14%
9%
9%
12%
PAT Growth
43%
46%
-8%
27%
15%
-23%
40%
89%
21%
-9%
 
EPS
11.38
10.63
7.26
7.86
6.18
5.38
6.99
4.99
2.65
2.18
2.41

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Shareholder's Funds
435
381
338
272
229
196
146
112
94
78
Share Capital
44
44
44
44
22
22
22
11
11
11
Total Reserves
391
337
294
227
207
174
124
101
82
67
Non-Current Liabilities
135
119
104
72
49
55
51
34
27
18
Secured Loans
111
91
79
48
31
40
39
24
18
12
Unsecured Loans
0
0
0
0
0
0
0
0
0
0
Long Term Provisions
4
3
2
3
3
2
2
1
1
1
Current Liabilities
229
181
123
114
109
113
89
68
61
57
Trade Payables
66
56
44
42
31
39
30
23
20
16
Other Current Liabilities
72
49
46
39
40
39
39
25
21
20
Short Term Borrowings
57
45
32
32
33
21
10
13
16
16
Short Term Provisions
34
31
0
0
5
14
11
6
4
4
Total Liabilities
800
682
565
457
387
364
286
214
182
153
Net Block
359
303
262
206
182
165
123
92
85
70
Gross Block
601
508
430
345
299
261
200
157
138
112
Accumulated Depreciation
241
205
169
139
116
96
77
65
52
42
Non Current Assets
450
352
310
252
217
205
166
120
101
88
Capital Work in Progress
25
19
18
20
14
10
20
8
5
8
Non Current Investment
13
11
10
4
4
4
3
4
2
2
Long Term Loans & Adv.
20
9
14
17
13
22
18
15
7
8
Other Non Current Assets
33
11
6
5
3
3
2
1
1
1
Current Assets
350
329
255
205
171
160
120
94
81
65
Current Investments
16
0
11
0
0
0
0
0
0
0
Inventories
112
84
73
62
46
58
42
35
30
25
Sundry Debtors
127
128
113
96
83
63
46
43
33
27
Cash & Bank
25
55
20
23
22
20
14
1
1
1
Other Current Assets
70
21
22
14
20
19
19
15
17
12
Short Term Loans & Adv.
56
41
17
10
11
10
9
8
9
7
Net Current Assets
121
148
133
91
61
47
31
27
20
8
Total Assets
800
682
565
457
387
364
286
214
182
153

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Cash From Operating Activity
130
106
75
56
63
63
66
39
33
22
PBT
124
99
96
75
65
65
53
33
29
23
Adjustment
55
44
40
23
26
43
33
19
18
13
Changes in Working Capital
-12
-9
-37
-24
-14
-21
-2
-6
-8
-9
Cash after chg. in Working capital
166
134
98
74
77
87
84
46
39
27
Interest Paid
0
0
0
0
0
0
0
0
0
0
Tax Paid
-36
-28
-23
-18
-14
-23
-18
-7
-6
-5
Other Direct Exp. Paid
0
0
0
0
0
0
0
0
0
0
Extra & Other Items
0
0
0
0
0
0
0
0
0
0
Cash From Investing Activity
-109
-101
-88
-56
-31
-59
-58
-31
-26
-24
Net Fixed Assets
-96
-44
-82
-51
-40
-49
-56
-22
-23
-16
Net Investments
-16
-24
-16
-1
0
0
1
0
0
0
Others
3
-33
10
-4
9
-11
-4
-9
-4
-7
Cash from Financing Activity
-21
-5
16
0
-31
-6
5
-8
-6
1
Net Cash Inflow / Outflow
1
1
3
0
1
-2
13
0
0
-1
Opening Cash & Equivalents
4
4
1
1
12
14
1
1
1
1
Closing Cash & Equivalent
5
4
4
1
13
12
14
1
1
1

Financial Ratios

Consolidated /

Standalone
Description
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Book Value (Rs.)
49
43
38
31
26
22
17
13
11
9
ROA
13%
10%
14%
13%
13%
19%
18%
12%
11%
15%
ROE
23%
18%
23%
22%
22%
36%
34%
23%
22%
31%
ROCE
24%
22%
25%
24%
26%
39%
39%
27%
28%
27%
Fixed Asset Turnover
1.24
1.30
1.35
1.44
1.49
1.71
1.83
1.79
1.76
1.65
Receivable days
68
72
73
71
64
50
50
53
50
51
Inventory Days
52
47
47
43
45
46
43
45
46
49
Payable days
42
38
39
37
39
41
40
40
40
38
Cash Conversion Cycle
78
81
81
76
70
55
53
58
56
62
Total Debt/Equity
0.47
0.42
0.39
0.37
0.36
0.40
0.46
0.43
0.49
0.53
Interest Cover
7
8
9
10
8
9
8
6
5
6

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.